Table 3 Relationship between FAM19A4 methylation and clinicopathological parameters in cervical cancer
Parameters | Median Methylation | Methylation Rates | U | P* |
|---|---|---|---|---|
Scores(\( \mathrm{P}\frac{1}{4}-\mathrm{P}\frac{3}{4} \)) | (%) | |||
Age | ||||
< 48 | 144.14(49.89–387.46) | 90.63(29/32) | 445.00 | 0.784 |
≥48 | 140.65(62.20–466.41) | 96.55(28/29) | ||
Histology | ||||
SCC | 145.37(62.54–450.44) | 94.44(51/54) | 144.00 | 0.321 |
AC/ASC | 137.83(8.38–207.24) | 85.71(6/7) | ||
Stage | ||||
IA or IB1 | 153.17(67.84–387.46) | 91.67(33/36) | 409.00 | 0.548 |
IB2 or above | 97.78(51.19–562.08) | 96.00(24/25) | ||
Size | ||||
≤4 cm | 141.42(62.20–389.23) | 93.88(46/49) | 279.00 | 0.786 |
> 4 cm | 123.54(23.42–807.25) | 91.67(11/12) | ||
Lymph node metastasis | ||||
yes | 167.28(77.43–604.86) | 100(10/10) | 227.00 | 0.585 |
no | 140.65(55.49–366.61) | 92.16(47/51) | ||